Stay updated on Tirzepatide in OSA: Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in OSA: Clinical Trial page.

Latest updates to the Tirzepatide in OSA: Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has removed the estimated timestamps for when results were first posted and last updated, which may affect users' understanding of the timeliness of the information provided.SummaryDifference0.1%
- Check31 days agoChange DetectedThe web page has been updated to reflect a new study on the effects of tirzepatide for participants with obstructive sleep apnea and obesity, including detailed information on dosing, study protocols, and outcome measures. Additionally, the reporting dates for results have been revised.SummaryDifference32%
- Check45 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the study's purpose, inclusion and exclusion criteria, and detailed descriptions of participant groups related to the evaluation of tirzepatide for obstructive sleep apnea and obesity. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference23%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Tirzepatide in OSA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in OSA: Clinical Trial page.